Providing HIV pre-exposure prophylaxis to men who have sex with men and transgender women in hospitals and community-led clinics in Thailand: acceptance, patterns of use, trends in risk behaviors, and HIV incidence

References

• Adams, J. L., Shelley, K., & Nicol, M. R. (2019). Review of real-world implementation data on emtricitabine-tenofovir disoproxil fumarate as HIV Pre-exposure prophylaxis in the United States. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 39(4), 486–500. https://doi.org/10.1002/phar.2240
   Google Scholar
• Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapia, M., Montoya-Herrera, O., Veloso, V. G., Mayer, K. H., Chariyalertsak, S., Schechter, M., Bekker, L. G., Kallas, E. G., & Grant, R. M. & iPrEx Study, T (2012). Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine, 4(151), 151ra125. https://doi.org/10.1126/scitranslmed.3004006
   PubMed Web of Science ®Google Scholar
• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kakia, A., Odoyo, J., … PartnersPrE. P. S. T. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. https://doi.org/10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Bavinton, B. R., & Grulich, A. E. (2021). HIV pre-exposure prophylaxis: Scaling up for impact now and in the future. The Lancet Public Health, 6(7), e528–e533. https://doi.org/10.1016/S2468-2667(21)00112-2
   PubMed Web of Science ®Google Scholar
• Blumenthal, J., & Haubrich, R. H. (2014). Will risk compensation accompany pre-exposure prophylaxis for HIV? AMA Journal of Ethics, 16(11), 909–915. https://doi.org/10.1001/virtualmentor.2014.16.11.stas1-1411
   Google Scholar
• Carlo Hojilla, J., Koester, K. A., Cohen, S. E., Buchbinder, S., Ladzekpo, D., Matheson, T., & Liu, A. Y. (2016). Sexual behavior, risk compensation, and HIV prevention strategies Among participants in the San Francisco PrEP demonstration project: A qualitative analysis of counseling notes. AIDS and Behavior, 20(7), 1461–1469. https://doi.org/10.1007/s10461-015-1055-5
   PubMed Web of Science ®Google Scholar
• CDC. Information about acute HIV infection and PrEP. Retrieved July 21, 2021 from https://www.cdc.gov/hiv/pdf/prep_gl_patient_factsheet_acute_hiv_infection_english.pdf
   Google Scholar
• CDC. (2017). Preexposure prophylaxis for the prevention of HIV infection in the United States 2021–2017 update: A clinical practice guideline. Retrieved from https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf
   Google Scholar
• CDC. (2021). Preexposure prophylaxis for the prevention of HIV infection in the United States 2021 update clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf
   Google Scholar
• Chan, P. A., Mena, L., Patel, R., Oldenburg, C. E., Beauchamps, L., Perez-Brumer, A. G., Parker, S., Mayer, K. H., Mimiaga, M. J., & Nunn, A. (2016). Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. Journal of the International AIDS Society, 19(1), Article 20903. https://doi.org/10.7448/IAS.19.1.20903
   Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., Vanichseni, S., & Bangkok Tenofovir Study, G. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• DDC. (2013). Guideline on HIV counseling & testing for same day result (in Thai). Retrieved from http://klb.ddc.moph.go.th/dataentry/handbook/form/31
   Google Scholar
• Dombrowski, J. C., Golden, M. R., Barbee, L. A., & Khosropour, C. M. (2018). Patient disengagement from an HIV preexposure prophylaxis program in a sexually transmitted disease clinic. Sexually Transmitted Diseases, 45(9), e62–e64. https://doi.org/10.1097/OLQ.0000000000000823
   PubMed Web of Science ®Google Scholar
• Estimation of People Living with HIV. (2020). https://hivhub.ddc.moph.go.th/epidemic.php
   Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapia, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., Montoya-Herrera, O., Fernandez, T., Veloso, V. G., Buchbinder, S. P., Chariyalertsak, S., Schechter, M., Bekker, L. G., Mayer, K. H., Kallas, E. G. & … iPrEx Study, T. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. https://doi.org/10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Grinsztejn, B., Hoagland, B., Moreira, R. I., Kallas, E. G., Madruga, J. V., Goulart, S., Leite, I. C., Freitas, L., Martins, L. M. S., Torres, T. S., Vasconcelos, R., De Boni, R. B., Anderson, P. L., Liu, A., Luz, P. M., Veloso, V. G., & Pr, E. P. B. S. T. (2018). Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. The Lancet HIV, 5(3), e136–e145. https://doi.org/10.1016/S2352-3018(18)30008-0
   PubMed Web of Science ®Google Scholar
• Haberer, J. E. (2016). Current concepts for PrEP adherence in the PrEP revolution. Current Opinion in HIV and AIDS, 11(1), 10–17. https://doi.org/10.1097/COH.0000000000000220
   PubMed Web of Science ®Google Scholar
• Han, J., Bouey, J. Z., Wang, L., Mi, G., Chen, Z., He, Y., Viviani, T., & Zhang, F. (2019). PrEP uptake preferences among men who have sex with men in China: Results from a National Internet Survey. Journal of the International AIDS Society, 22(2), e25242. https://doi.org/10.1002/jia2.25242
   PubMed Web of Science ®Google Scholar
• Hoornenborg, E., Coyer, L., van Laarhoven, A., Achterbergh, R., de Vries, H., Prins, M., van der Loeff, M. S., & Amsterdam Pr, E. P. P. t. i. t. H. I. V. T. E. A. I(2018). Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: Results from the Amsterdam pre-exposure prophylaxis demonstration project. Aids (london, England), 32(11), 1527–1532. https://doi.org/10.1097/QAD.0000000000001874
   PubMed Web of Science ®Google Scholar
• Jenness, S. M., Sharma, A., Goodreau, S. M., Rosenberg, E. S., Weiss, K. M., Hoover, K. W., Smith, D. K., & Sullivan, P. (2017). Individual HIV risk versus population impact of risk compensation after HIV preexposure prophylaxis initiation among Men Who have Sex with Men. PLoS One, 12(1), e0169484. https://doi.org/10.1371/journal.pone.0169484
   PubMed Web of Science ®Google Scholar
• Kazi, D. S., Katz, I. T., & Jha, A. K. (2019). Preparing to End the HIV epidemic — California’s route as a road Map for the United States. New England Journal of Medicine, 381(26), 2489–2491. https://doi.org/10.1056/NEJMp1912293
   PubMed Web of Science ®Google Scholar
• Lachowsky, N. J., Lawson Tattersall, T., Sereda, P., Wang, C., Edwards, J., & Hull, M. (2019). Community awareness of, use of and attitudes towards HIV pre-exposure prophylaxis (PrEP) among men who have sex with men in Vancouver, Canada: Preparing health promotion for a publicly funded PrEP program. Sexual Health, 16(2), 180–186. https://doi.org/10.1071/SH18115
   PubMed Web of Science ®Google Scholar
• Landovitz, R. J., Donnell, D., Clement, M. E., Hanscom, B., Cottle, L., Coelho, L., Cabello, R., Chariyalertsak, S., Dunne, E. F., Frank, I., Gallardo-Cartagena, J. A., Gaur, A. H., Gonzales, P., Tran, H. V., Hinojosa, J. C., Kallas, E. G., Kelley, C. F., & Losso, M. H., Madruga, J. V., … Team, H. S (2021). Cabotegravir for HIV prevention in cisgender Men and transgender women. New England Journal of Medicine, 385(7), 595–608. https://doi.org/10.1056/NEJMoa2101016
   PubMed Web of Science ®Google Scholar
• Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., Liegler, T., Rawlings, M. K., Trainor, N., Blue, R. W., Estrada, Y., Coleman, M. E., Cardenas, G., Feaster, D. J., Grant, R., … Kolber, M. A. (2016). Preexposure prophylaxis for HIV infection integrated With municipal- and community-based sexual health services. JAMA Internal Medicine, 176(1), 75–84. https://doi.org/10.1001/jamainternmed.2015.4683
   PubMed Web of Science ®Google Scholar
• Martin, M., Vanichseni, S., Suntharasamai, P., Sangkum, U., Mock, P. A., Chaipung, B., Worrajittanon, D., Leethochawalit, M., Chiamwongpaet, S., Kittimunkong, S., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Holtz, T. H., Samandari, T., Choopanya, K., & Bangkok Tenofovir Study, G. (2017). Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: An observational, open-label extension of the Bangkok Tenofovir Study. The Lancet HIV, 4(2), e59–e66. https://doi.org/10.1016/S2352-3018(16)30207-7
   PubMed Web of Science ®Google Scholar
• Milam, J., Jain, S., Dube, M. P., Daar, E. S., Sun, X., Corado, K., Ellorin, E., Blumenthal, J., Haubrich, R., Moore, D. J., Morris, S. R., & Team, C. (2019). Sexual risk compensation in a Pre-exposure prophylaxis demonstration study Among individuals at risk of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes, 80(1), e9–e13. https://doi.org/10.1097/QAI.0000000000001885
   PubMed Web of Science ®Google Scholar
• NHSO. (2020). UCS: 10 outstanding accomplishments in 2020. Retrieved from https://eng.nhso.go.th/view/1/DescriptionNews/UCS-10-outstanding-accomplishments-in-2020/267/EN-US
   Google Scholar
• Niderost, S., Gredig, D., Hassler, B., Uggowitzer, F., & Weber, P. (2018). The intention to use HIV-pre-exposure prophylaxis (PrEP) among men who have sex with men in Switzerland: Testing an extended explanatory model drawing on the unified theory of acceptance and use of technology (UTAUT). Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health, 26(3), 247–259. https://doi.org/10.1007/s10389-017-0869-1
   PubMed Web of Science ®Google Scholar
• Ongwandee, S., Lertpiriyasuwat, C., Khawcharoenporn, T., Chetchotisak, P., Thiansukhon, E., Leerattanapetch, N., Leungwaranan, B., Manopaiboon, C., Phoorisri, T., Visavakum, P., Jetsawang, B., Poolsawat, M., Nookhai, S., Vasanti-Uppapokakorn, M., Karuchit, S., Kittinunvorakoon, C., Mock, P., Prybylski, D., Sukkul, A. C., … Martin, M. (2018). Implementation of a test, treat, and prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016. PLoS One, 13(7), e0201171. https://doi.org/10.1371/journal.pone.0201171
   PubMed Web of Science ®Google Scholar
• PEPFAR. (2021). PEPFAR technical guidance in context of COVID-19 pandemic. Retrieved July 7, 20/21 from https://www.state.gov/wp-content/uploads/2020/09/9.17.2020-PEPFAR-Technical-Guidance-During-COVID.pdf
   Google Scholar
• Phanuphak, N., Sungsing, T., Jantarapakde, J., Pengnonyang, S., Trachunthong, D., Mingkwanrungruang, P., Sirisakyot, W., Phiayura, P., Seekaew, P., Panpet, P., Meekrua, P., Praweprai, N., Suwan, F., Sangtong, S., Brutrat, P., Wongsri, T., Na Nakorn, P. R., Mills, S., Avery, M., … Phanuphak, P. (2018). Princess PrEP program: The first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sexual Health, 15(6), 542–555. https://doi.org/10.1071/SH18065
   PubMed Web of Science ®Google Scholar
• Plotzker, R., Seekaew, P., Jantarapakde, J., Pengnonyang, S., Trachunthong, D., Linjongrat, D., Janyam, S., Nakpor, T., Charoenying, S., Mills, S., Vannakit, R., Cassell, M., Phanuphak, P., Lertpiriyasuwat, C., & Phanuphak, N. (2017). Importance of risk perception: Predictors of PrEP acceptance among Thai MSM and TG women at a community-based health service. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76(5), 473–481. https://doi.org/10.1097/QAI.0000000000001536
   PubMed Web of Science ®Google Scholar
• Sivay, M. V., Li, M., Piwowar-Manning, E., Zhang, Y., Hudelson, S. E., Marzinke, M. A., Amico, R. K., Redd, A., Hendrix, C. W., Anderson, P. L., Bokoch, K., Bekker, L. G., van Griensven, F., Mannheimer, S., Hughes, J. P., Grant, R., Eshleman, S. H., & Team, H. A. S. (2017). Characterization of HIV seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75(3), 271–279. https://doi.org/10.1097/QAI.0000000000001374
   PubMed Web of Science ®Google Scholar
• Spinelli, M. A., Scott, H. M., Vittinghoff, E., Liu, A. Y., Gonzalez, R., Morehead-Gee, A., Gandhi, M., & Buchbinder, S. P. (2019). Missed visits associated With future preexposure prophylaxis (PrEP) discontinuation Among PrEP users in a municipal primary care health network. Open Forum Infectious Diseases, 6(4), ofz101. https://doi.org/10.1093/ofid/ofz101
   PubMed Web of Science ®Google Scholar
• Tangmunkongvorakul, A., Chariyalertsak, S., Amico, K. R., Saokhieo, P., Wannalak, V., Sangangamsakun, T., Goicochea, P., & Grant, R. (2013). Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care, 25(8), 961–967. https://doi.org/10.1080/09540121.2012.748871
   PubMed Web of Science ®Google Scholar
• Thailand National Guidelines on HIV/AIDS Treatment and Prevention 2017. (2017). Retrieved 29 November 2019 from http://www.thaiaidssociety.org/images/PDF/hiv_thai_guideline_2560.pdf
   Google Scholar
• Thienkrua, W., van Griensven, F., Mock, P. A., Dunne, E. F., Raengsakulrach, B., Wimonsate, W., Howteerakul, N., Ungsedhapand, C., Chiwarakorn, A., & Holtz, T. H. (2018). Young men who have sex with men at high risk for HIV, Bangkok MSM cohort study, Thailand 2006-2014. AIDS and Behavior, 22(7), 2137–2146. https://doi.org/10.1007/s10461-017-1963-7
   PubMed Web of Science ®Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L. I., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., & Sukalac, T., Thomas, V. T., … Group, T. D. F. S. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. https://doi.org/10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2016). Prevention GAP report. Retrieved from https://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf
   Google Scholar
• van Griensven, F., Holtz, T. H., Thienkrua, W., Chonwattana, W., Wimonsate, W., Chaikummao, S., Varangrat, A., Chemnasiri, T., Sukwicha, W., Curlin, M. E., Samandari, T., Chitwarakorn, A., & Mock, P. A. (2015). Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006–13: An observational study Bangkok, Thailand, 2006-13: An observational study. The Lancet HIV, 2(2), e64–e70. https://doi.org/10.1016/S2352-3018(14)00031-9
   PubMed Web of Science ®Google Scholar
• van Griensven, F., Thienkrua, W., McNicholl, J., Wimonsate, W., Chaikummao, S., Chonwattana, W., Varangrat, A., Sirivongrangson, P., Mock, P. A., Akarasewi, P., & Tappero, J. W. (2013). Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand. Aids (london, England), 27(5), 825–832. https://doi.org/10.1097/QAD.0b013e32835c546e
   PubMed Web of Science ®Google Scholar
• van Griensven, F., Varangrat, A., Wimonsate, W., Tanpradech, S., Kladsawad, K., Chemnasiri, T., Suksripanich, O., Phanuphak, P., Mock, P., Kanggarnrua, K., McNicholl, J., & Plipat, T. (2010). Trends in HIV prevalence, estimated HIV incidence, and risk behavior among men who have sex with men in Bangkok, Thailand, 2003–2007, estimated HIV incidence, and risk behavior among men who have sex with men in Bangkok, Thailand, 2003-2007. JAIDS Journal of Acquired Immune Deficiency Syndromes, 53(2), 234–239. https://doi.org/10.1097/QAI.0b013e3181c2fc86
   PubMed Web of Science ®Google Scholar
• Vannakit, R., Janyam, S., Linjongrat, D., Chanlearn, P., Sittikarn, S., Pengnonyang, S., Janamnuaysook, R., Termvanich, K., Ramautarsing, R., Phanuphak, N., & Phanuphak, P. (2020). Give the community the tools and they will help finish the job: Key population-led health services for ending AIDS in Thailand. Journal of the International AIDS Society, 23(6), e25535. https://doi.org/10.1002/jia2.25535
   PubMed Web of Science ®Google Scholar
• Wasantioopapokakorn, M., Manopaiboon, C., Phoorisri, T., Sukkul, A., Lertpiriyasuwat, C., Ongwandee, S., Langkafah, F., Kritsanavarin, U., Visavakum, P., Jetsawang, B., Nookhai, S., Kitwattanachai, P., Weerawattanayotin, W., Losirikul, M., Yenyarsun, N., Jongchotchatchawal, N., & Martin, M. (2018). Implementation and assessment of a model to increase HIV testing among men who have sex with men and transgender women in Thailand, 2011-2016. AIDS Care, 30(10), 1239–1245. https://doi.org/10.1080/09540121.2018.1492697
   PubMed Web of Science ®Google Scholar
• Wheelock, A., Eisingerich, A. B., Ananworanich, J., Gomez, G. B., Hallett, T. B., Dybul, M. R., & Piot, P. (2013). Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One, 8(1), e54288. https://doi.org/10.1371/journal.pone.0054288
   PubMed Web of Science ®Google Scholar
• WHO. (2019a). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Retrieved from https://www.who.int/publications/i/item/9789241509565
   Google Scholar
• WHO. (2019b). Technical brief: What’s the 2 + 1 + 1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: Update to who’s recommendation on oral PrEP. Retrieved from https://www.who.int/publications/i/item/what-s-the-2-1-1-event-driven-oral-pre-exposure-prophylaxis-to-prevent-hiv-for-men-who-have-sex-with-men
   Google Scholar
• Yang, D., Chariyalertsak, C., Wongthanee, A., Kawichai, S., Yotruean, K., Saokhieo, P., Guadamuz, T., Suwanvanichkij, V., Beyrer, C., & Chariyalertsak, S. (2013). Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand. PLoS One, 8(10), e76650. https://doi.org/10.1371/journal.pone.0076650
   PubMed Web of Science ®Google Scholar
• Zablotska, I., Grulich, A. E., Phanuphak, N., Anand, T., Janyam, S., Poonkasetwattana, M., Baggaley, R., van Griensven, F., & Lo, Y. R. (2016). PrEP implementation in the Asia-pacific region: Opportunities, implementation and barriers. Journal of the International AIDS Society, 19(7(Suppl 6)), 21119. https://doi.org/10.7448/IAS.19.7.21119.
   Google Scholar
• Zucker, J., Carnevale, C., Richards, P., Slowikowski, J., Borsa, A., Gottlieb, F., Vakkur, I., Hyden, C., Olender, S., Cohall, A., Gordon, P., & Sobieszczyk, M. E. (2019). Predictors of disengagement in care for individuals receiving Pre-exposure prophylaxis (PrEP). JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(4), 104–108. https://doi.org/10.1097/QAI.0000000000002054.
   PubMed Web of Science ®Google Scholar